Clinical trial
Medical Treatment With or Without Transcatheter Patent Foramen Ovale CloSure for Older Patients With CrypTogenic StrOke and Patent Foramen Ovale. The STOP Trial
NCT05907694 is registered in ClinicalTrials.gov with Josep Rodes-Cabau as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Medical Treatment With or Without Transcatheter Patent Foramen Ovale CloSure for Older Patients With CrypTogenic StrOke and Patent Foramen Ovale. The STOP Trial
- Lead sponsor
- Josep Rodes-Cabau
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- June 18, 2024
- Completion date
- October 1, 2037
- Enrollment
- 714 (estimated)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
cryptogenic stroke, medical treatment, older patients, patent foramen ovale, recurrent stroke